# First Quote Outbound Packet Gate

Date checked: 2026-06-15
Status: packet assembly gate, not contact permission and not treatment advice

## Direct Answer

The next blocker is packet assembly. The first quote materials are now
organized enough to prepare a founder-review packet, but not to send it.
Contact remains blocked until explicit founder approval and recipient
qualification are recorded.

Current operational label:

`case001_first_quote_outbound_packet_gate_ready_for_founder_review`

## Packet Components

| Component | Required state |
| --- | --- |
| Approval state | Founder approval must be explicit before send. |
| Recipient state | Recipient class must pass the June 8 qualification gate. |
| Cover note | Use only public-safe preclinical language. |
| Quote table | Use the June 2 first quote table. |
| Held addenda | Keep ginger extract, `T-BDMC`, and metabolism endpoints out of required first-quote lines. |
| Capability questions | Ask for model, HbF or `HBG`, maturation, viability, alpha-globin/autophagy, hemolysis or membrane safety, raw data, cost, timeline, ethics, biosafety, and material constraints. |
| Public source links | Use source URLs only, not private records. |
| Response path | Use the June 13 response-capture gate for any reply. |

## Decision Labels

| Label | Meaning |
| --- | --- |
| `packet_ready_for_founder_review` | Public-safe packet components are assembled, but contact is still blocked. |
| `packet_send_blocked_no_approval` | Packet is otherwise coherent, but approval is absent. |
| `packet_hold_missing_component` | A required public-safe component or recipient label is missing. |
| `packet_reject_private_or_clinical_scope` | Packet includes private data, patient samples, treatment, trial, purchase, import, or procurement language. |

## Source Read

The June 15 PubMed refresh did not change the packet. Current erythroid,
gamma-globin, metabolism, and editing benchmark records reinforce the same
requirements: model, endpoints, controls, safety, raw data, cost, timeline, and
boundaries must be explicit.

## Boundary

This gate does not send email, choose a recipient, authorize contact, request
patient samples, or provide diagnosis, dosing, trial screening, travel,
purchase, import, procurement, or treatment advice.

## Islamic Motivation Boundary

Quran 49:6 supports verification before acting on consequential reports. Here
that means assembling and checking the packet before any send decision. It is
not biomedical evidence for any lab, assay, material, or treatment.

## Sources

- [Workflow JSON](../../../data/workflows/case-001/2026-06-15-first-quote-outbound-packet-gate.json)
- [June 15 PubMed compact snapshot](../../../data/literature/pubmed/2026-06-15-first-quote-outbound-packet-refresh.json)
- [Lab quote request template](../../../templates/lab-quote-request-template.md)
- [First quote request table](2026-06-02-first-quote-request-table.md)
- [Lab outreach approval gate](2026-06-07-lab-outreach-approval-gate.md)
- [Lab recipient qualification gate](2026-06-08-lab-recipient-qualification-gate.md)
- [First quote response-capture gate](2026-06-13-first-quote-response-capture-gate.md)
- [Quran 49:6 verification anchor](../../islamic/quran/049-al-hujurat/006.md)
- [PubMed PMID `41411145`](https://pubmed.ncbi.nlm.nih.gov/41411145/)
- [PubMed PMID `41184165`](https://pubmed.ncbi.nlm.nih.gov/41184165/)
- [PubMed PMID `41347631`](https://pubmed.ncbi.nlm.nih.gov/41347631/)
